Leukemia Clinical Trials in Seattle

Showing 701-720 of 759 trials

Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

NCT00138242

RATIONALE: Drugs used in chemotherapy, such as docetaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving docetaxel together with carboplatin works in treating patients with ovarian epithelial, fallopian tube, or peritoneal cavity cancer.

Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer

Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center30 participantsStarted Dec 2004

Seattle, Washington, United States

COMPLETEDPhase 2< 1 mile

Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation

NCT00737516

The National Marrow Donor Program (NMDP) has established a system for registering, matching, and tracking unrelated donor cord blood units (CBUs) and transplant outcomes. Study subjects are donors who enroll through collaborating cord blood banks. This study creates uniform collection, screening, testing and storage requirements for cord blood units. The purpose of standardization is to improve efficiency in the selection of cord blood units for transplantation.

LeukemiaLymphomaMyelodysplastic Syndromes

National Marrow Donor Program3,621 participantsStarted Jan 2000

Covina, California, United States • Orange, California, United States • San Diego, California, United States +16 more locations

Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation

Leukemia Trials in Other Cities

Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer

S9912 Combination Chemo in Stage III Ovarian Cancer,

Iressa Expanded Access Program (EAP)

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia

A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia

Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

Collaborative H1N1 Adjuvant Treatment Pilot Trial

Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)

Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)

Other Conditions in Seattle